Komori
Financial results presentation7061Japan Hospice Holdings Inc.Information and Communications, Services and Others

FAQ on Financial Results for the Third Quarter of the Fiscal Year Ending December 2026

The company explained changes in revenue per unit and the number of users following the revision of medical service fees, the challenges involved in returning to profitability, and its track record of joint development with Sugi Holdings. It also indicated that it would defer announcing the earnings and dividend forecasts for the fiscal year ending December 2026, as well as business plans for 2027 and beyond, until reasonable estimates can be calculated.

Worth reading
40Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Contents of this document

Summary of Q&AQ3 of the fiscal year ending December 20267 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Full-year earnings forecastWithdrawn. To be announced again once reasonable figures can be calculated
What the company explained in this material
Key points of the Q&AKey questions raised by investors at the briefing and the company's answers
  1. Impact of the revision of medical service fees: medical insurance revenue fell by approximately ¥200,000 per resident per month immediately after the revision, but revenue per unit improved through various measures. The number of users began recovering from October after declining.
  2. Return to profitability: recovery in operating volume and adjustment of the balance between operating volume and staff numbers are required to return to profitability.
  3. Earnings and dividend forecasts: the immediate impact and winter bonuses have not been finalized, making reasonable calculations difficult. The forecasts will be announced once they can be calculated.
  4. Business plans from 2027 onward: the impact of the revision of medical service fees and facility development plans are under review, and the announcement timing is undetermined.
  5. Impact of interest rate increases: most interest expense consists of accounting amounts associated with finance leases, so the impact is limited.
  6. Alliance with Sugi Holdings: joint development has been completed at 7 facilities, and approximately 10 facilities are under discussion.
  7. Equity offering: the company generally considers equity financing unnecessary, but will make a comprehensive decision based on financial indicators, market conditions and other factors.
  8. Recruitment: applications exceeded the number of available positions, and no facility opening has previously been delayed due to recruitment.
  9. Leased and company-owned facilities: approximately 90% of all facilities are operated under lease arrangements. The company plans to monetize its company-owned properties in the future.
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
The impact of the revision of medical service fees, the amount of the winter 2026 bonus and the certainty of facility opening plans are under review. Numerical assumptions: Not disclosed
New initiatives
  • Optimization of residential rents and other charges
  • Improvement in home-visit nursing productivity
  • Improving the collection rate for Life Plan fees
  • Sales initiatives prioritizing the recovery of operating volume
  • Adjusting staff numbers in line with the recovery in operating volume
  • Joint development and collaboration on hospice facilities with Sugi Holdings
Key KPIsA metric the company considers important as a management benchmark.
  • Decrease in medical insurance revenue per residentApproximately ¥200,000
  • Decrease in the number of users from the end of June to the end of September162 people
  • Increase in the number of users from the end of SeptemberApproximately 30
  • Percentage of facilities operated under lease arrangementsApproximately 90%
Unit price and quantity metricsThese figures show sales broken down by price and volume.
The company explained the balance between revenue per resident, operating volume, occupancy rate and staff numbers. Revenue per unit improves each month, while operating volume has been recovering since October.
Financial targets
The company cited the equity ratio and other factors as considerations in deciding whether to raise capital, but target and actual figures are Not disclosed
Annual Dividend
The dividend forecast has been withdrawn. Amount and breakdown: Not disclosed
Contents of this document
ItemDetails
Document typeSummary of Q&A
Fiscal Period CoveredQ3 of the fiscal year ending December 2026
Full-year earnings forecastWithdrawn. To be announced again once reasonable figures can be calculated
Key KPIsIndicator name Decrease in medical insurance revenue per resident / Value Approximately ¥200,000 / Year on year against the same period last year Not disclosed, Indicator name Decrease in the number of users from the end of June to the end of September / Value 162 people / Year on year against the same period last year Not disclosed, Indicator name Increase in the number of users from the end of September / Value Approximately 30 / Year on year against the same period last year Not disclosed, Indicator name Percentage of facilities operated under lease arrangements / Value Approximately 90% / Year on year against the same period last year Not disclosed
Unit price and quantity metricsThe company explained the balance between revenue per resident, operating volume, occupancy rate and staff numbers. Revenue per unit improves each month, while operating volume has been recovering since October.
Assumptions Underlying the Business OutlookThe impact of the revision of medical service fees, the amount of the winter 2026 bonus and the certainty of facility opening plans are under review. Numerical assumptions: Not disclosed
Financial targetsThe company cited the equity ratio and other factors as considerations in deciding whether to raise capital, but target and actual figures are Not disclosed
Annual DividendThe dividend forecast has been withdrawn. Amount and breakdown: Not disclosed
Key points of the Q&AImpact of the revision of medical service fees: medical insurance revenue fell by approximately ¥200,000 per resident per month immediately after the revision, but revenue per unit improved through various measures. The number of users began recovering from October after declining., Return to profitability: recovery in operating volume and adjustment of the balance between operating volume and staff numbers are required to return to profitability., Earnings and dividend forecasts: the immediate impact and winter bonuses have not been finalized, making reasonable calculations difficult. The forecasts will be announced once they can be calculated., Business plans from 2027 onward: the impact of the revision of medical service fees and facility development plans are under review, and the announcement timing is undetermined., Impact of interest rate increases: most interest expense consists of accounting amounts associated with finance leases, so the impact is limited., Alliance with Sugi Holdings: joint development has been completed at 7 facilities, and approximately 10 facilities are under discussion., Equity offering: the company generally considers equity financing unnecessary, but will make a comprehensive decision based on financial indicators, market conditions and other factors., Recruitment: applications exceeded the number of available positions, and no facility opening has previously been delayed due to recruitment., Leased and company-owned facilities: approximately 90% of all facilities are operated under lease arrangements. The company plans to monetize its company-owned properties in the future.
New initiativesOptimization of residential rents and other charges, Improvement in home-visit nursing productivity, Improving the collection rate for Life Plan fees, Sales initiatives prioritizing the recovery of operating volume, Adjusting staff numbers in line with the recovery in operating volume, Joint development and collaboration on hospice facilities with Sugi Holdings
Items this document does not state (21)
Net SalesOperating profitOrdinary incomeNet incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planSegment resultsBreakdown of Factors Affecting the ChangeNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / Share

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company considers it difficult to calculate a reasonable earnings forecast at this time because revenue and earnings have been changing due to the impact of the revision of medical service fees and the amount of the winter 2026 bonus has not been finalized. For plans from 2027 onward, it stated that it needs to examine the impact of the fee revision and improve the certainty of its facility opening plans.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FAQ on Financial Results for the Third Quarter of the Fiscal Year Ending December 2026 | Japan Hospice Holdings Inc. (7061) timely disclosure | Komori